glucagon has been researched along with brl 26830a in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (brl 26830a) | Trials (brl 26830a) | Recent Studies (post-2010) (brl 26830a) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 39 | 5 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, T | 1 |
| Hiraoka, N; Kondo, M; Yoshida, T | 1 |
2 other study(ies) available for glucagon and brl 26830a
| Article | Year |
|---|---|
The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Ethanolamines; Female; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1992 |
Effects of a beta 3-adrenoceptor agonist, BRL 26830A, on insulin and glucagon release in mice.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Ethanolamines; Female; Glucagon; Insulin; Islets of Langerhans; Mice; Mice, Inbred ICR; Receptors, Adrenergic, beta; Streptozocin; Time Factors | 1991 |